Area of research
Genetics · Immunology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Immunodeficiency and Autoimmune Disorders, Lymphoma Diagnosis and Treatment, and Monoclonal and Polyclonal Antibodies Research.
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival.
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism.
Evidence that chronic lymphocytic leukemia arises from a multiclonal selection process
Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli.
Activated CLL cells regulate IL-17F–producing Th17 cells in miR155-dependent and outcome-specific manners
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process
Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions